← NOVAVAX INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $15.4m | $31.2m | $34.3m | $18.7m | $475.6m | $1.1b | $2.0b | $983.7m | $682.2m | $1.1b | |
| Cost of Goods and Services Sold | $5.6m | $11.5m | $12.6m | $6.9m | $174.7m | $421.1m | $902.6m | $343.8m | $202.7m | $73.0m | |
| Gross Profit (Calculated) (derived) | $9.7m | $19.7m | $21.7m | $11.8m | $300.9m | $725.2m | $1.1b | $639.9m | $479.4m | $1.1b | |
| Operating expenses: | |||||||||||
| Operating Income (Loss) | ($269.1m) | ($171.7m) | ($173.9m) | ($120.6m) | ($416.7m) | ($1.7b) | ($644.7m) | ($566.5m) | ($248.9m) | $452.8m | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | $800k | $2.2m | $700k | $700k | $600k | $400k | — | — | — | — | |
| Goodwill, Impairment Loss | — | — | — | $0 | — | — | — | $0 | $0 | $0 | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $269.1m | $171.7m | $173.9m | $120.6m | $416.7m | ($1.6b) | ($712.2m) | ($629.0m) | ($261.9m) | $426.3m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $269.1m | $171.7m | $173.9m | $120.6m | $416.7m | ($1.7b) | ($653.6m) | ($543.0m) | ($176.6m) | $442.2m | |
| Investment Income, Net | $2.1m | $1.9m | $2.7m | $1.5m | $1.0m | $1.4m | — | — | — | — | |
| Net Income (Loss) Attributable to Parent | ($280.0m) | ($183.8m) | ($184.7m) | ($132.7m) | ($418.3m) | ($1.7b) | ($657.9m) | ($545.1m) | ($187.5m) | $440.3m | |
| Net Income (Loss) Available to Common Stockholders, Basic | ($280.0m) | ($183.8m) | ($184.7m) | ($132.7m) | ($418.3m) | ($1.7b) | ($657.9m) | ($545.1m) | ($187.5m) | $440.3m | |
| Earnings Per Share, Basic | — | — | — | ($5.51) | ($7.27) | ($23.44) | ($8.42) | ($5.41) | ($1.23) | $2.72 | |
| Earnings Per Share, Diluted | ($1.03) | ($0.63) | ($0.50) | ($5.51) | ($7.27) | ($23.44) | ($8.42) | ($5.41) | ($1.23) | $2.58 | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | — | 74.4m | 78.2m | 100.8m | 152.2m | 162.0m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | — | 74.4m | 78.2m | 100.8m | 152.2m | 173.1m | |
| Research and Development Expense | $237.9m | $168.4m | $173.8m | $113.8m | $747.0m | $2.5b | $1.2b | $737.5m | $391.2m | $342.3m | |
| General and Administrative Expense | $46.5m | $34.5m | $34.4m | $34.4m | $145.3m | $298.4m | $488.7m | $468.9m | $337.2m | $157.5m | |
| Selling, General and Administrative Expense | $46.5m | $34.5m | $34.4m | $34.4m | $145.3m | $298.4m | $488.7m | $468.9m | $337.2m | $157.5m | |
| Other Nonoperating Income (Expense) | ($31k) | $67k | $108k | ($13k) | $12.6m | ($8.2m) | $11.0m | $37.9m | $40.4m | $40.6m | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $20.1m | $22.5m | |
| Costs and Expenses | $284.5m | $202.9m | $208.2m | $139.2m | $892.3m | $2.8b | $2.6b | $1.6b | $931.1m | $670.7m | |
| Current Income Tax Expense (Benefit) | — | — | — | — | — | — | $4.3m | ($12k) | $12.3m | $1.9m | |
| Interest Expense | $13.0m | $14.1m | $13.6m | $13.6m | $15.1m | $21.1m | $19.9m | $14.4m | $20.1m | $22.5m | |
| Interest Expense, Debt | $12.5m | $13.6m | $13.6m | $13.6m | $13.6m | $13.6m | $14.0m | $11.5m | $10.4m | $11.5m | |
| Restructuring Costs | $3.6m | — | — | — | — | — | — | — | — | — | |
| Income Tax Expense (Benefit) | — | — | — | — | — | $29.2m | $4.3m | $2.0m | $10.9m | $1.9m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.